Mode
Home
Conditions Medications Drug Pipeline Weekly Digests Questions
Text Size
Log in / Sign up
Home › Conditions › Hemophilia A

Hemophilia A

Part of Blood Coagulation Disorders, Inherited

3 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis finds non-clotting factor therapies reduce bleeding in congenital hemophilia
Hematology Meta-analysis
Meta-analysis finds non-clotting factor therapies reduce bleeding in congenital hemophilia Can new therapies help people with hemophilia bleed less and live better?
This meta-analysis of 6 RCTs (397 participants) synthesizes evidence on non-clotting factor therapies for bleed prevention in congenital hem…
For people with hemophilia, frequent bleeding can disrupt daily life and cause pain.
Apr 16, 2026
Gene therapy reduces bleeding rates and factor use in adults with severe hemophilia A
Hematology Meta-analysis
Gene therapy reduces bleeding rates and factor use in adults with severe hemophilia A Can gene therapy reduce bleeding and treatment burden for adults with severe hemophilia A?
A systematic review and meta-analysis of adults with severe/moderately severe hemophilia A found gene therapy reduced annualized bleeding ra…
For adults with severe hemophilia A, gene therapy may offer a way to bleed less and rely far less on regular infusions.
Apr 4, 2026
Concizumab Reduces Bleeding in Hemophilia with Inhibitors: Median ABR 0.8 at 56 Weeks
Hematology RCT
Concizumab Reduces Bleeding in Hemophilia with Inhibitors: Median ABR 0.8 at 56 Weeks Could a New Treatment Change the Lives of People with Hemophilia?
In the phase 3 explorer7 RCT, concizumab prophylaxis significantly reduced median annualized bleeding rate (ABR) to 0.8 in patients with hem…
A new treatment for hemophilia helped patients with inhibitors experience just one bleeding episode a year, offering hope for fewer interrup…
Mar 27, 2026

Questions about Hemophilia A

Do non-clotting factor therapies work for both Hemophilia A and Hemophilia B?

Non-clotting factor therapies like emicizumab and concizumab are effective for preventing bleeding in both Hemophilia A and Hemophilia B.

Full answer →
How much does gene therapy reduce bleeding rates for adults with severe Hemophilia A?

Gene therapy reduces annualized bleeding rates in adults with severe Hemophilia A by a standardized mean difference of -0.72 compared to standard factor treatment, though bleeding rates can rise again if the treatment wears off.

Full answer →
Do non-clotting factor therapies actually reduce bleeding in congenital Hemophilia A?

Yes, non-clotting factor therapies like emicizumab and concizumab significantly reduce bleeding rates in people with congenital Hemophilia A compared to no treatment or standard clotting factor prophylaxis.

Full answer →